|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01515 CR MEDICAL
Nominal 
4.130 -0.070 (-1.667%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 1.638% | 1.880% | 4.302% | 3.684% | 5.145% |
| ROAE (%) | 3.364% | 3.332% | 6.657% | 5.165% | 6.802% |
| Return on Capital Employed (%) | 3.051% | 2.094% | 5.950% | 4.590% | 6.023% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 18.856% | 16.527% | 20.991% | 23.140% | 36.037% |
| EBITDA Margin (%) | 10.482% | 10.113% | 6.974% | 15.780% | 26.107% |
| Pre-tax Profit Margin (%) | 4.877% | 5.353% | 6.082% | 15.203% | 25.589% |
| Net Profit Margin (%) | 2.549% | 3.365% | 9.397% | 11.275% | 18.478% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 0.659 X | 1.320 X | 1.140 X | 1.879 X | 2.310 X |
| Quick Ratio (X) | 0.600 X | 1.249 X | 1.086 X | 1.814 X | 2.266 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 48.638% | 40.206% | 34.594% | 29.261% | 22.019% |
| Total Debt / Total Assets (%) | 16.928% | 13.480% | 16.512% | 8.373% | 7.585% |
| Net Debt / Total Assets (%) | 7.875% | -3.919% | -5.691% | -21.766% | -17.894% |
| Total Debt / Shareholders' Funds (%) | 39.769% | 25.265% | 26.793% | 12.292% | 10.116% |
| Long Term Debt / Shareholders' Funds (%) | 17.008% | 11.072% | 0.624% | 0.766% | 0.230% |
| Net Debt / Shareholders' Funds (%) | 18.501% | -7.346% | -9.234% | -31.953% | -23.866% |
| Net Cash / (Debt) ($) | (1.075B) | 698.288M | 595.677M | 1.951B | 1.409B |
| Net Cash / (Debt) per share ($) | (0.829) | 0.539 | 0.459 | 1.505 | 1.087 |
| Total Debt / Capital Employed (%) | 27.364% | 18.921% | 24.607% | 11.108% | 9.203% |
| Interest Coverage Ratio (X) | 5.291 X | 8.566 X | 17.661 X | 25.572 X | 33.938 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 14.899 Day | 15.289 Day | 16.989 Day | 17.623 Day | 18.884 Day |
| Receivables Turnover (Day) | 54.643 Day | 52.137 Day | 56.821 Day | 82.059 Day | 96.387 Day |
| Payables Turnover (Day) | 62.578 Day | 59.173 Day | 57.108 Day | 53.438 Day | 40.151 Day |
| Remarks: | Real time quote last updated: 06/11/2024 17:30 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 433,949 |
| %Change | 9.121% |
| EPS / (LPS) | RMB 0.340 |
| NBV Per Share (¥) | RMB 4.758 |